Educational Reference · Research-Use-Only
Glutathione: Mechanism, Research, and Regulatory Status
A research-grade overview of Glutathione — what it is, how it works at the molecular level, what published studies have shown, and answers to the questions researchers ask most.
Last reviewed 2026-07-28
What is Glutathione?
Glutathione is the most abundant low-molecular-weight thiol in mammalian cells, typically present at 1 to 10 millimolar intracellularly, and it is synthesized enzymatically rather than assembled on ribosomes. Synthesis proceeds in two ATP-dependent steps: glutamate-cysteine ligase, the rate-limiting enzyme and feedback-inhibited by glutathione itself, forms gamma-glutamylcysteine, and glutathione synthetase adds glycine. Cysteine availability is the principal substrate constraint on flux, which is why cysteine-delivering precursors rather than the intact tripeptide dominate the interventional literature.
Functionally, the cysteinyl thiol acts as the reducing equivalent for glutathione peroxidases, which reduce hydrogen peroxide and lipid hydroperoxides, and for peroxiredoxin and glutaredoxin systems that reverse protein S-glutathionylation; the resulting oxidized disulfide is recycled by NADPH-dependent glutathione reductase, coupling glutathione redox status directly to the pentose phosphate pathway. The ratio of reduced to oxidized glutathione is therefore a principal determinant of cytosolic and mitochondrial redox potential and a widely used experimental readout of oxidative stress. In phase II biotransformation, glutathione S-transferases conjugate glutathione to electrophilic xenobiotics and reactive metabolites, and the conjugates are exported and processed through the mercapturic acid pathway.
Extracellular glutathione is not taken up intact by most cells: it is degraded at the cell surface by gamma-glutamyltransferase and the constituent amino acids are re-imported for intracellular resynthesis. This catabolic gate is the mechanistic reason oral glutathione shows poor systemic availability as the intact tripeptide.
Research highlights
What published peer-reviewed research and preclinical studies have established about Glutathione:
- 01Glutamate-cysteine ligase is the rate-limiting step of glutathione synthesis and is feedback-inhibited by glutathione itself, so intracellular concentration is substrate- and enzyme-constrained rather than freely elevated by supply of the intact tripeptide.
- 02NEGATIVE FOUNDATIONAL FINDING: a single 3 g oral dose in 7 healthy volunteers produced no significant increase in plasma glutathione, cysteine or glutamate over 270 minutes; the authors concluded dietary glutathione is not a major determinant of circulating glutathione (Witschi 1992).
- 03NULL FINDING: a randomized, double-blind, placebo-controlled trial of oral glutathione 500 mg twice daily for 4 weeks in 40 healthy adults found no significant change in biomarkers of oxidative stress or in glutathione status (Allen and Bradley 2011).
- 04CONTRASTING FINDING: a 6-month randomized trial in 54 non-smoking adults reported dose-dependent increases in glutathione across blood compartments (Richie 2015); this and the null trials above are not easily reconciled, and the oral-glutathione literature should be treated as genuinely conflicting rather than settled.
- 05Older adults show markedly reduced erythrocyte glutathione synthesis rates on stable-isotope infusion; supplying the precursor amino acids cysteine and glycine for 2 weeks restored glutathione concentrations and normalized oxidative stress markers, supporting a precursor-limitation model (Sekhar 2011).
- 06IMPORTANT CAVEAT: common claims for oral or injected glutathione — skin lightening, detoxification, anti-aging — are not supported by adequate controlled evidence; the strong evidence supports glutathione's cellular roles, not supplement efficacy.
Published clinical and preclinical research
The systemic availability of oral glutathione
Open pharmacokinetic study in healthy volunteers · 1992NEGATIVE. No significant increase in plasma glutathione, cysteine or glutamate; degradation by intestinal and hepatic gamma-glutamyltransferase implicated. Concluded that dietary glutathione is not a major determinant of circulating glutathione.
Oral glutathione and systemic oxidative stress biomarkers
Randomized, double-blind, placebo-controlled trial · 2011NEGATIVE. Glutathione 500 mg twice daily produced no significant change in oxidative stress biomarkers or glutathione status.
Oral glutathione supplementation and body stores of glutathione
Randomized, double-blind, placebo-controlled trial · 2015POSITIVE but in conflict with the trials above. Dose-dependent increases of 17-260% across compartments at 250 or 1000 mg/day, with decreased oxidative stress markers in the high-dose group.
Cysteine and glycine supplementation in aging (stable-isotope study)
Controlled metabolic study with intervention arm · 2011Elderly subjects had markedly reduced glutathione synthesis versus younger subjects; 2 weeks of cysteine plus glycine restored glutathione concentration and normalized oxidative stress markers. Precursor delivery, not intact glutathione.
Frequently asked questions about Glutathione
What is glutathione?+
Glutathione is an endogenous tripeptide, L-gamma-glutamyl-L-cysteinylglycine. Its distinguishing structural feature is the gamma-linkage from glutamate, which makes it resistant to ordinary peptidase cleavage; it is degraded specifically by gamma-glutamyltransferase.
What is the difference between GSH and GSSG, and why does the ratio matter?+
GSH is the reduced monomeric thiol; GSSG is the oxidized disulfide dimer formed when two GSH molecules are oxidized. The GSH/GSSG ratio is a standard experimental index of cellular redox state, maintained by NADPH-dependent glutathione reductase. Because GSH autoxidizes on the bench, accurate measurement requires handling that prevents artefactual oxidation.
How does glutathione differ from N-acetylcysteine?+
N-acetylcysteine is a cysteine prodrug that supplies the rate-limiting substrate for intracellular glutathione synthesis; glutathione is the finished tripeptide. Because extracellular glutathione is largely cleaved by gamma-glutamyltransferase before uptake, cysteine-delivering compounds are the more common experimental route for raising intracellular glutathione.
Why is glutathione unstable in solution?+
The free thiol is readily autoxidized to the disulfide, a reaction accelerated by neutral-to-alkaline pH, dissolved oxygen and trace transition metals such as copper and iron. Common practice is to prepare solutions fresh in degassed, slightly acidic buffer, include a chelator such as EDTA, minimize headspace and light exposure, and quantify free thiol rather than relying on the weighed-in concentration.
Does oral glutathione raise systemic glutathione?+
The published evidence is conflicting and should be described as such. A 1992 pharmacokinetic study found no measurable systemic availability after a 3 g oral dose, and a 2011 four-week randomized trial found no change in glutathione status or oxidative stress biomarkers; a 2015 six-month trial reported dose-dependent increases in blood compartments. Precursor-based approaches have more consistent mechanistic support.
References & sources
Every citation below was resolved against its primary source before publication — each PMID against the PubMed record and each DOI through doi.org. Follow any link to read the paper at the publisher rather than taking our summary on trust.
- [1]Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Molecular Aspects of Medicine. 2009. PMID: 18796312 DOI: 10.1016/j.mam.2008.08.006
- [2]Lu SC. Regulation of glutathione synthesis. Molecular Aspects of Medicine. 2009. PMID: 18601945 DOI: 10.1016/j.mam.2008.05.005
- [3]Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione. European Journal of Clinical Pharmacology. 1992. PMID: 1362956 DOI: 10.1007/BF02284971
- [4]Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. Journal of Alternative and Complementary Medicine. 2011. PMID: 21875351 DOI: 10.1089/acm.2010.0716
- [5]Richie JP Jr, Nichenametla S, Neidig W, et al.. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. European Journal of Nutrition. 2015. PMID: 24791752 DOI: 10.1007/s00394-014-0706-z
- [6]Sekhar RV, Patel SG, Guthikonda AP, et al.. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. American Journal of Clinical Nutrition. 2011. PMID: 21795440 DOI: 10.3945/ajcn.110.003483
Where this data comes from
- —Citations & trial data: PubMed (NCBI, U.S. National Library of Medicine), Crossref and ClinicalTrials.gov.
- —Chemical identity: PubChem and UniProt. Where sources conflicted, the disputed value is omitted rather than guessed.
- —Regulatory status: U.S. FDA publications and, where applicable, the WADA Prohibited List. Compounding status changes frequently — verify against FDA directly before relying on it.
- —Purity, form and storage are handling and supplier conventions, not literature-derived values. Confirm against the lot-specific certificate of analysis.
Content last reviewed 2026-07-28. Compiled by Veridian Research from the primary literature. This page is an educational reference for laboratory researchers — it is not medical advice, and it describes no human use.
Regulatory status
Glutathione is an endogenous human metabolite and a common laboratory reagent. It is not an FDA-approved drug for any indication in the United States. Oral glutathione is marketed as a dietary supplement ingredient, meaning it is regulated as a food-category product and has not undergone FDA pre-market review for safety or efficacy for any specific use. Injectable and intravenous glutathione preparations are unapproved drug products; no glutathione formulation is FDA-approved for injection, and its inclusion on the FDA 503A bulk drug substances list for pharmacy compounding has been contested, with FDA citing insufficient effectiveness and safety data. Glutathione for skin lightening by injection is not an FDA-approved use and has been the subject of safety advisories by national regulators. Research-grade glutathione supplied for laboratory use is neither a drug nor a dietary supplement and is intended solely for in vitro and non-human research.
Research-Use-Only Material
Specifications and certificate of analysis
Glutathione is stocked as a research reagent. Analytical documentation — identity, purity and the lot-specific certificate of analysis — is published on the product record.
View specifications & COA →